The predictive value of 18F-FDG-PET to demonstrate disease activity in patients with relapsed multiple myeloma; a pilot study

The predictive value of 18F-FDG-PET to demonstrate disease activity in patients with relapsed multiple myeloma; a pilot study - FDG-PET in relapsed MM.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32803

Enrollment

Registered

2009-02-18

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kahler's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Relapsed multiple myeloma patients that demonstrate increased disease activity

Exclusion criteria

Exclusion criteria: -Ineligible to perform a scan -Age =250 µM.

Design outcomes

Primary

Measure	Time frame
- To define the increase of FDG-PET uptake in relapsed MM in comparison to SRS and X-ray examination.	—

Countries

Netherlands

Outcome results